NCT00364845View on ClinicalTrials.gov

STIMULATE Study: Anemia Correction and Health-related Quality of Life (HRQoL) Outcomes in Elderly Chronic Kidney Disease (CKD) Patients

PHASE3TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

February 28, 2009

Conditions

AnemiaChronic Kidney Disease

Interventions

DRUG

Darbepoetin alfa

Starting dose was calculated at 0.75 micrograms per kilogram (μg/kg) body weight at randomization, rounded to nearest prefilled syringe dose unit. Dose was titrated incrementally. Monthly dose was initially double the every 2 week dose at time of conversion.

DRUG

Placebo

Prefilled syringe placebo, to match active arm